Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_assertion type Assertion NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_head.
- NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_assertion description "[Collectively our data show that monitoring Hh pathway activity contemporaneously with BCR-ABL1 mRNA level may improve the chance of early detection of patients who will experience a relapse (mainly in the high Sokal risk group), paving the way for an innovative management of this hematologic malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_provenance.
- NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_assertion evidence source_evidence_literature NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_provenance.
- NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_assertion SIO_000772 22762548 NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_provenance.
- NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_assertion wasDerivedFrom befree-20150227 NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_provenance.
- NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_assertion wasGeneratedBy ECO_0000203 NP219458.RA2BYLDCH0OniAESbootqkXVOL3PGc9F5JZslWRVRxOJQ130_provenance.